In research literature, Thymulin is generally treated as a zinc-dependent thymic nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) secreted by thymic epithelial cells and studied in T-lymphocyte differentiation assay models. Thymulin requires a 1:1 stoichiometric complex with Zn²⁺ for biological activity in receptor-binding and T-cell differentiation assays — the metal-free form (facteur thymique serique, FTS) is inactive. Upon Zn²⁺ coordination, thymulin promotes CD4/CD8 double-positive thymocyte maturation and the acquisition of T-cell receptor signalling competence. It has also been studied for modulation of inflammatory cytokine secretion profiles and NK cell activity in peripheral blood assay systems. Because circulating zinc levels determine the active/inactive ratio of endogenous thymulin, in vitro experiments must control Zn²⁺ concentration to produce interpretable results.
Thymulin is used primarily as a thymopoiesis research tool and as a reference peptide for zinc-dependent peptide-receptor interaction studies. Comparative experiments using zinc-chelated (EDTA-treated) versus zinc-supplemented conditions allow researchers to toggle between inactive and active forms and cleanly attribute observed effects to thymulin rather than the zinc ion alone. For laboratory teams, the practical emphasis is usually on sequence identity, receptor or pathway relevance where documented, and whether Thymulin behaves consistently across stability, purity, and analytical verification workflows. Variant labels on this page support clearer internal referencing when multiple labelled variants are under review.